@article{bf5a08e7d095472ba8c384576f03e9ae,
title = "Sepsis-induced renal failure: Ischemia or toxemia?",
keywords = "Acute kidney injury, Oxygen, Reactive oxygen species, Renal tubular epithelium, Severe sepsis",
author = "Crouser, \{Elliott D.\}",
note = "Funding Information: *See also p. e318. Key Words: acute kidney injury; oxygen; reactive oxygen species; renal tubular epithelium; severe sepsis Dr. Crouser{\textquoteright}s institution received funding from Beckman Coulter, the National Institutes of Health/National Heart, Lung, and Blood Institute, and the Foundation for Sarcoidosis Research, and he disclosed that Bristol Meyer Squib supports his role as a site principal investigator for a sepsis clinical trial using one of their products (this trial recently ended, and he does not receive support at this time).",
year = "2018",
month = apr,
doi = "10.1097/CCM.0000000000002970",
language = "English",
volume = "46",
pages = "658--660",
journal = "Critical Care Medicine",
issn = "0090-3493",
number = "4",
}